KhosrowMahdaviMDFACP
Oncology • Costa Mesa, CAClinical Professor Hematology,Oncology, University of California Irvine.
Dr. Mahdavi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1640 Newport Blvd
Ste 400
Costa Mesa, CA 92627Phone+1 949-999-2400Fax+1 949-999-2405
Education & Training
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1978 - 1979
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 1976 - 1977
Loyola University Medical Center/Trinity-Mercy ChicagoResidency, Internal Medicine, 1974 - 1976
Grant Hospital of ChicagoResidency, Family Medicine, 1973 - 1974- Grant Hospital of ChicagoInternship, Transitional Year, 1972 - 1973
Tehran University of Medical Sciences School of MedicineClass of 1969
Certifications & Licensure
IL State Medical License 1974 - Present
CA State Medical License 1979 - 2026
OH State Medical License 1977 - 1979- American Board of Internal Medicine Internal Medicine
- National Board of Physicians and Surgeons Hematology
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 1995
Publications & Presentations
PubMed
- Investigation of Effectiveness of Nowarta110 Against Murine Malignant Melanoma in an Implanted Animal Model.Jon Sin, Matei Kiosea, Nicolae Kiosea, Khosrow Mahdavi, Ferre Akbarpour
Anticancer Research. 2024-12-01 - Investigation of the Efficacy of Nowarta110 in the Treatment of HPV-16 and HPV-18 Oncogenically-transformed Human Cells and Cancer-implanted Animal Models.Jon Sin, Matei Kiosea, Khosrow Mahdavi, Ferre Akbarpour, Jolie Nguyen
Anticancer Research. 2024-11-01 - 17 citationsDendritic Versus Tumor Cell Presentation of Autologous Tumor Antigens for Active Specific Immunotherapy in Metastatic Melanoma: Impact on Long-Term Survival by Extent ...Robert O. Dillman, Edward F. McClay, Neil M. Barth, Thomas Amatruda, Lee S. Schwartzberg
Cancer Biotherapy & Radiopharmaceuticals. 2015-06-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
